Horizon Discovery Group PLC (LSE:HZD) - Share price - Overview

Stock Report

Horizon Discovery Group PLC HZD

Last Price
GBX256.00

Day Change
2.50|0.99%

As of 27/07/2017
17:15:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close253.50p
Day Range250.00 - 256.00
Mkt Cap244.80Mil
52-Wk Range104.00 - 275.00
Yield %0.00
ISINGB00BK8FL363
Volume137,966
P/E-23.86
P/S10.05
P/CF-29.83

Share Price

Total Returns 27/07/2017

 Chg (%)  
More ...
Horizon Discovery Group PLC26.76 
FTSE 100 TR GBP0.20
 
Financials
201420152016
More ...
Income Statement
Turnover11.9120.1624.07
Operating Profit-6.11-10.29-12.36
Net Profit-5.92-9.88-11.43
Reported EPS-9.20-11.20-12.10
Balance Sheet
Current Assets25.8136.5120.59
Non Current Assets39.9352.3666.81
Total Assets65.7488.8787.40
Current Liabilities5.876.788.70
Total Liabilities7.179.019.51
Total Equity58.5779.8677.89
Cash Flow
Operating Cash Flow-6.62-11.08-8.52
Net Change in Cash14.276.60-19.37
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-6.35-4.00--63.38---
2018-2.51-1.29--197.12---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/12/2016PurchaseDr. Darrin Disley117.0025,00029,250.00
02/12/2016PurchaseMr. Richard Vellacott117.0010,00011,700.00
02/12/2016PurchaseDr. Susan Galbraith119.7540,00047,900.00
01/12/2016PurchaseDr. Ian Gilham117.9025,00029,475.00

Company Profile

Horizon Discovery Group PLC is one of the leading medical technology companies in the United Kingdom. Its activities mainly include the application of gene editing and building cells that harbor the genetics of human disease.

Sector

Biotechnology

Market Position

660 of 1846 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(05/06/2017) ch - " In the year ahead we expect to continue to build momentum, and I look forward to updating you as we continue our progress"

Next Event 20/09/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-102.7014.5316.61
Div Yld (E)0.003.804.14
PEG (E)0.000.521.01
ROCE-41.43191.4513.38
Op Mrgn-44.59-5.404.56
EPS Grwth0.0035.1630.94
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Ian Gilham
Chief Executive OfficerDr. Darrin Disley
Chief Financial Officer & Company SecretMr. Richard Vellacott
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.